News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
243,021 Results
Type
Article (6314)
Company Profile (17)
Press Release (236690)
Section
Business (87451)
Career Advice (466)
Deals (16399)
Drug Delivery (8)
Drug Development (21440)
Employer Resources (30)
FDA (4340)
Job Trends (4304)
News (130345)
Policy (8648)
Tag
Academia (306)
Alliances (16441)
Alzheimer's disease (247)
Approvals (4355)
Artificial intelligence (33)
Bankruptcy (103)
Best Places to Work (3051)
Breast cancer (44)
Cancer (392)
Career advice (395)
Cell therapy (88)
Clinical research (17987)
Collaboration (146)
Compensation (129)
COVID-19 (321)
C-suite (78)
Data (456)
Diabetes (40)
Diagnostics (2119)
Earnings (42164)
Employer resources (31)
Events (39422)
Executive appointments (261)
FDA (4551)
Funding (157)
Gene therapy (39)
GLP-1 (111)
Government (444)
Healthcare (5231)
Infectious disease (336)
Interviews (53)
IPO (8132)
Job creations (1342)
Job search strategy (364)
Layoffs (101)
Legal (2725)
Lung cancer (42)
Manufacturing (44)
Medical device (4082)
Medtech (4083)
Mergers & acquisitions (8432)
Metabolic disorders (111)
Neuroscience (330)
NextGen: Class of 2025 (1725)
Non-profit (743)
Northern California (760)
Obesity (50)
Opinion (31)
People (25879)
Phase I (5217)
Phase II (7683)
Phase III (6362)
Pipeline (367)
Postmarket research (835)
Preclinical (1986)
Press Release (66)
Prostate cancer (25)
Radiopharmaceuticals (107)
Rare diseases (62)
Real estate (2007)
Regulatory (5797)
Research institute (325)
Resumes & cover letters (68)
Southern California (561)
Startups (1097)
United States (5927)
Vaccines (38)
Date
Today (4)
Last 7 days (185)
Last 30 days (760)
Last 365 days (11279)
2025 (1377)
2024 (11677)
2023 (13937)
2022 (20390)
2021 (21248)
2020 (19730)
2019 (14246)
2018 (11010)
2017 (11221)
2016 (10364)
2015 (13650)
2014 (10701)
2013 (8450)
2012 (9078)
2011 (9476)
2010 (9337)
Location
Africa (192)
Arizona (52)
Asia (12012)
Australia (1675)
California (1573)
Canada (614)
China (49)
Colorado (67)
Connecticut (79)
Delaware (25)
Europe (35479)
Florida (208)
Georgia (28)
Illinois (107)
Indiana (53)
Japan (55)
Maine (37)
Maryland (194)
Massachusetts (1319)
Michigan (80)
Minnesota (122)
New Jersey (460)
New York (401)
North Carolina (307)
Northern California (760)
Ohio (48)
Pennsylvania (309)
South America (299)
Southern California (561)
Texas (181)
Utah (49)
Virginia (40)
Washington State (144)
243,021 Results for "prothena corporation plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prothena Announces Board of Directors Update
December 31, 2024
·
3 min read
Press Releases
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
February 14, 2025
·
1 min read
Business
Prothena to Report First Quarter 2024 Financial Results on May 8
Prothena Corporation plc announced that it will report its first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
May 1, 2024
·
1 min read
Press Releases
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights
February 20, 2025
·
17 min read
Prothena to Participate in Upcoming March 2024 Healthcare Conferences
Prothena Corporation plc announced that members of its senior management team will participate in the following upcoming investor conferences.
March 5, 2024
·
1 min read
Business
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, reported financial results for the first quarter of 2024 and provided business highlights.
May 8, 2024
·
13 min read
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that Bristol Myers Squibb obtained the exclusive global license for PRX019 and will pay Prothena $80 million.
May 28, 2024
·
4 min read
Business
Prothena Appoints David Ford to Newly Created Chief People Officer Position
Prothena Corporation plc announced that it has named David Ford to a newly created position of Chief People Officer, reporting to Prothena President and Chief Executive Officer Gene Kinney, PhD.
March 4, 2024
·
3 min read
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
Prothena Corporation plc announced the publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab, a potential best-in-class anti-amyloid treatment for AL amyloidosis.
April 15, 2024
·
4 min read
Press Releases
Prothena to Report Third Quarter 2024 Financial Results on November 12
November 5, 2024
·
1 min read
1 of 24,303
Next
